Related references
Note: Only part of the references are listed.The Prevention and Treatment of Missing Data in Clinical Trials: An FDA Perspective on the Importance of Dealing With It
R. T. O'Neill et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Missing Data
James H. Ware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The Prevention and Treatment of Missing Data in Clinical Trials
Roderick J. Little et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
LAST OBSERVATION CARRIED FORWARD: A CRYSTAL BALL?
Michael G. Kenward et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2009)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Steven E. Kahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Statistical considerations in the intent-to-treat principle
JM Lachin
CONTROLLED CLINICAL TRIALS (2000)
Share Paper
